ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia
10.3324/haematol.2019.230482
Saved in:
Main Authors: | Zhou, J., Quah, J.Y., Ng, Y., Chooi, J.-Y., Toh, S.H.-M., Lin, B., Tan, T.Z., Hosoi, H., Osato, M., Seet, Q., Lisa Ooi, A.G., Lindmark, B., McHale, M., Chng, W.-J. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
Ferrata Storti Foundation
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198181 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.
by: Zhou, Jianbiao, et al.
Published: (2022) -
Purification and characterization of enzyme dihydroorotate dehydrogenase in plasmodium falciparum
by: Nattaprapa Suriyamontol
Published: (2013) -
Depression of Plasmodium falciparum dihydroorotate dehydrogenase activity in in vitro culture by tetracycline
by: Phisit Prapunwattana, et al.
Published: (2018) -
High-performance liquid chromatographic determination of dihydroorotate dehydrogenase of Plasmodium falciparum and effects of antimalarials on enzyme activity
by: Isra Ittarat, et al.
Published: (2018) -
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
by: Zhou, J, et al.
Published: (2020)